HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Orofacial Granulomatosis

A condition characterized by persistent or recurrent labial enlargement, ORAL ULCER, and other orofacial manifestations in the absence of identifiable CROHN DISEASE; or SARCOIDOSIS. Among experts there is disagreement on whether orofacial granulomatosis is a distinct clinical disorder or an initial presentation of Crohn disease.
Also Known As:
Granulomatosis, Orofacial; Granulomatoses, Orofacial; Orofacial Granulomatoses
Networked: 78 relevant articles (4 outcomes, 2 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Crohn Disease (Crohn's Disease)
2. Contact Dermatitis (Eczema, Contact)
3. Hypersensitivity (Allergy)
4. Allergic Contact Dermatitis
5. Aphthous Stomatitis (Aphthous Ulcer)

Experts

1. Sanderson, J D: 4 articles (04/2016 - 03/2004)
2. Escudier, Michael: 3 articles (03/2021 - 06/2006)
3. Challacombe, S J: 3 articles (12/2013 - 03/2004)
4. Escudier, M P: 3 articles (12/2013 - 03/2004)
5. Elliott, Tim: 2 articles (01/2020 - 01/2011)
6. Escudier, Michael P: 2 articles (01/2019 - 01/2019)
7. Sanderson, Jeremy D: 2 articles (01/2019 - 06/2006)
8. Patel, P: 2 articles (04/2016 - 10/2011)
9. Fedele, S: 2 articles (04/2014 - 08/2004)
10. Campbell, H E: 2 articles (12/2013 - 10/2011)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Orofacial Granulomatosis:
1. Triamcinolone (Aristocort)FDA Link
2. Benzoates (Benzoate)IBA
3. Infliximab (Remicade)FDA Link
4. Azathioprine (Imuran)FDA LinkGeneric
5. Food Additives (Food Additive)IBA
6. SteroidsIBA
7. Thalidomide (Thalomid)FDA Link
8. Adrenal Cortex Hormones (Corticosteroids)IBA
9. Azithromycin (Zithromax)FDA LinkGeneric
10. Biomarkers (Surrogate Marker)IBA

Therapies and Procedures

1. Injections
2. Therapeutics
3. Oral Medicine
4. Nerve Block (Nerve Blocks)
5. Lasers (Laser)